ReviewJournal of molecular and cellular cardiology2019

HDAC inhibition as a therapeutic strategy in myocardial ischemia/reperfusion injury.

Min Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.